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Background: The present interdisciplinary consensus review
proposes clinical considerations and recommendations for anaes-
thetic practice in patients undergoing gastrointestinal surgery
with an Enhanced Recovery after Surgery (ERAS) programme.
Methods: Studies were selected with particular attention being
paid to meta-analyses, randomized controlled trials and large
prospective cohort studies. For each item of the perioperative
treatment pathway, available English-language literature was
examined and reviewed. The group reached a consensus recom-
mendation after critical appraisal of the literature.
Results: This consensus statement demonstrates that anaesthesi-
ologists control several preoperative, intraoperative and postoper-
ative ERAS elements. Further research is needed to verify the
strength of these recommendations.
Conclusions: Based on the evidence available for each element of
perioperative care pathways, the Enhanced Recovery After Sur-
gery (ERAS ) Society presents a comprehensive consensus
review, clinical considerations and recommendations for anaesthe-
sia care in patients undergoing gastrointestinal surgery within an
ERAS programme. This unified protocol facilitates involvement of
anaesthesiologists in the implementation of the ERAS pro-
grammes and allows for comparison between centres and it even-
tually might facilitate the design of multi-institutional prospective
and adequately powered randomized trials.
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Editorial comment: what this article tells us
This consensus paper includes a number of recommendations to enhance recovery in patients
undergoing gastrointestinal surgery. Preoperatively, optimization of medical disease and cessation
of smoking and alcohol intake are emphasized. Prevention of nausea and vomiting is important.
Careful titration of anaesthetics and ensuring full recovery of neuromuscular blockade are recom-
mended. During surgery, there should be normal values of arterial oxygen level, intraoperative
temperature and glucose concentration. The article also includes recommendations regarding fluid
therapy, opioid-sparing analgesia and mobilization.
Over 234 million major surgical procedures are
performed globally each year1 and despite
advances in surgical and anaesthetic care, mor-
bidity after abdominal surgery is still high2.
Fast-track or enhanced recovery after surgery
(ERAS) clinical pathways have been proposed
to improve the quality of perioperative care with
the aim of attenuating the loss of functional
capacity and accelerating the recovery process3.
The ERAS pathways reduce the delay until full
recovery after major abdominal surgery by atten-
uating surgical stress and maintaining postopera-
tive physiological functions. The implementation
of the ERAS pathways has been shown to impact
positively in reducing postoperative morbidity,
and as a consequence, length of stay in hospital
(LOSH) and its related costs4–9.
In recent years, several studies have high-
lighted the impact of the anaesthetic management
on postoperative morbidity and mortality10–13. In
view of the evidence that many elements of the
ERAS programme published by the ERAS Soci-
ety in 2009 are of related to anaesthetic care, it is
imperative that guidelines on perioperative care
include recommendations approved by an inter-
disciplinary team comprising anaesthesiologists
and surgeons3.
As a follow-up of the previous manuscript14
where the pathophysiological basis of the ERAS
were analysed, this article represents an effort of
the ERAS Society (www.erassociety.org) to pre-
sent a consensus review of clinical considera-
tions, including recommendations, for optimal
anaesthesia care for patients undergoing gas-
trointestinal surgery within the ERAS pro-
gramme. It is not the purpose of this manuscript
to provide detailed information about each sin-
gle ERAS element and for each type of gastroin-
testinal surgical procedure. Most of the ERAS
elements have been already discussed exten-
sively, specifically for different types of surgical
procedures, as well the quality of evidence sup-
porting each ERAS element15–19. It must be
acknowledged that evidence supporting some of
the ERAS elements still remains controversial.
Methods
An interdisciplinary group of physicians, anaes-
thesiologists and surgeons who are experts in
the field of ERAS programmes were invited to
participate in the preparation of this consensus
statement.
Literature search
The authors met in October 2012 and the topics
for inclusion were agreed upon and allocated. The
principal literature search utilized MEDLINE,
Embase and Cochrane databases to identify contri-
butions related to the topic published between
January 1966 and May 2014. Medical Subject
Headings (MeSH) terms were used, as were
accompanying entry terms for the patient group,
interventions and outcomes. Key words included
“‘anesthesia’’, “anaesthesia”, “analgesia”, “sur-
gery”, “‘enhanced recovery’’ and “‘fast track’’. Ref-
erence lists of all eligible articles were checked for
other relevant studies. Conference proceedings
were not searched. Expert contributions came
from within the ERAS Society Working Party.
Study selection, assessment and data analyses of the
identified trials
Based on the literature search, titles and
abstracts were screened by individual reviewers
to identify reviews, case series, non-randomized
studies, randomized control studies, meta-ana-
lyses and systematic reviews that were consid-
ered for each individual topic. Discrepancies in
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judgment were resolved by the senior author
and during committee meetings of the ERAS
Society Working Party.
Recommendations
Recommendations were made by the panel based
on the evidence supporting each ERAS element.
Specifically, “Strong recommendations” indicate
that the panel was confident that the desirable
effects of adherence to a recommendation out-
weighed the undesirable effects. “Weak recom-
mendations” indicate that the desirable effects of
adherence to a recommendation probably out-
weighed the undesirable effects, but the panel
was less confident. Recommendations were based
on the balance between desirable and undesirable
effects, and on values and preferences.
Part A. Preoperative ERAS elements
An ERAS approach to preoperative
evaluation
Pre-admission risk stratification
Risk scoring systems have been used to try
and identify which patients are at higher risk
of death and complications from major surgery.
Up to 80% of postoperative deaths come from
this high-risk group20. It is imperative not
only to provide patients with an overview of
the risk of surgery but also to select those
patients for further investigation and optimiza-
tion and decide which perioperative care path-
way the patients should be on for resource
allocation. In a major retrospective study in
the USA, Khuri et al. analysed data on
105,951 patients undergoing a variety of differ-
ent specialty major surgical procedures. The
striking result was that if patients had a major
complication within 30 days of surgery then it
reduced median survival by 69% at 8 years21.
Therefore, identification for risk factors for any
major complication of surgery is also impor-
tant.
Scoring systems for surgery. Many different scoring
systems, some of them procedure-specific, have
been developed for patients undergoing surgery.
The purpose of this section is to give an over-
view of the most common scoring system use in
clinical practice beside the well known Ameri-
can Society of Anesthesiologists (ASA) physical
status score.
POSSUM scores: in 1991, Copeland et al.
described the POSSUM (Physiological and
Operative Severity Scoring for the enUmeration
of Mortality and morbidity) scoring system for
general surgical patients22. This is a two part
scoring system based on physiological assess-
ment (12 variables) and operative severity (six
variables). Each variable has a 1–4 point range
depending on severity. The system predicts 30-
day risk for mortality (matrix for the 50% pre-
diction of risk of mortality: specificity = 99.3%
and sensitivity = 54.1%) and morbidity (matrix
for the 50% prediction of risk of morbidity:
specificity = 92.4% and sensitivity = 52.1%).
The Portsmouth POSSUM (P-POSSUM) better
predicts postoperative mortality23, as the origi-
nal POSSUM logistic regression equation over-
predicts mortality especially in low-risk
patients. POSSUM has been also modified
slightly for different specialties such as colorec-
tal24, oesophageal25 and vascular surgery26 to try
and improve sensitivity and specificity for these
specialties.
Assessing cardiac risk in non-cardiac surgery—Cardio-
vascular risk can be predicted by multivariate
risk incidences that include clinical and surgi-
cal criteria, and biological markers27–29. These
tools have been incorporated in the recent
ACC/AHA 2014 guidelines on perioperative
cardiovascular evaluation and care for non-car-
diac surgery.30
The Lee index—The Lee Index is a modification
of the original Goldman cardiac risk index31. It
comprises six independent clinical determinants
of major perioperative cardiac events:
1. History of ischaemic heart disease (IHD)
2. History of cerebrovascular disease
3. Heart failure
4. Preoperative insulin treatment for diabetes
mellitus
5. Serum creatinine > 177 lmol/l
6. High-risk type of surgery
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All factors contribute 1 point equally to the
index, and for patients with an index of 0, 1, 2
and 3 points the incidence of major cardiac com-
plications is estimated at 0.4%, 0.9%, 7% and
11% respectively.31
Cardiovascular Risk Calculator—A similar tool
to determine the postoperative probability of
myocardial infarct or cardiac arrest has been val-
idated by Gupta and colleagues in 211,410
patients undergoing surgery. It contains five
independent predictors28:
1. Type of surgery
2. Dependent functional status (inability to per-
form activities of daily living in the 30 days
before surgery, partially independent or
totally independent)
3. Abnormal serum creatinine
4. American Society of Anesthesiologists class
(ASA)
5. Increasing age
More recently there has been increasing
awareness that perioperative myocardial injury
does not always present with any of the typical
ischaemic features of chest pain, electrocardio-
gram changes, rhythm disturbance or heart fail-
ure. The VISION study measured troponins and
showed a spectrum of results with 44% of tro-
ponin rises fulfilling the criteria for myocardial
injury without fulfilling a traditional definition
of perioperative myocardial infarction32.
Assessment of functional capacity. Estimating func-
tional capacity is an important start of assessing a
patient. Functional capacity is measured in meta-
bolic equivalents (METs). One MET equals the
basal metabolic rate at rest. Climbing one flight
of stairs demands 4 METs and strenuous activity
such as playing tennis or swimming is > 10
METS. The inability to perform 4 METS indicates
poor functional capacity and is associated with
an increased incidence of postoperative cardiac
events.33 The presence of good functional capac-
ity, even in the presence of stable IHD or other
risk factors is associated with a good outcome.34
As patients poorly estimate their functional
capacity, it is important to obtain an independent
assessment using dynamic testing.
Dynamic Tests
Walk Tests—(2 min, 6 min, shuttle) All these
tests measure the distance covered over a set
period of time by the patient. They have been
validated in clinical practice and are easy to
administer.35,36 Norms according to age and
gender have been created. Although they corre-
lated with cardiopulmonary testing, they have
not been used to determine whether to operate
or not on patients undergoing high-risk surgery.
Cardiopulmonary Exercise Testing (CPET)—
This is a dynamic non-invasive objective test
that evaluates the ability of a patient’s car-
diopulmonary system to adapt to a sudden
increase in oxygen demand. The ramped exer-
cise test is performed on a cycle ergometer with
ECG monitoring and analysis of expired carbon
dioxide and oxygen consumption, the later
being directly related to oxygen delivery and a
linear function of cardiac output when exercis-
ing. With increasing exercise, oxygen consump-
tion will eventually exceed oxygen delivery.
Aerobic metabolism becomes inadequate to
meet the metabolic demands and blood lactate
rises reflecting supplementary anaerobic meta-
bolism. The value for oxygen consumption at
this point is known as the anaerobic threshold
(AT), expressed as ml/kg/min VO2 peak/max
can also be measured. Both values have been
used to try and predict the risk of complications.
Older’s original work in colorectal patients
showed that if a patient’s AT was less than
11 ml/kg/min, the patients was at higher risk of
complications which was increased if there was
the presence of ischaemic heart disease.37,38
Snowden et al. showed that an AT cut-off value
of 10.1 ml/kg/min predicts complications better
than an algorithm-based activity assessment
(Veterans Activity Questionnaire Index
[VASI]).39 Similarly, in patients undergoing
pancreatic, hepatic and vascular surgery and AT
< 10 ml/kg/min predicts complications and
early postoperative death40–43. VO2 max has also
been studied to predict outcome and has been
shown to be a sensitive marker for cardiopul-
monary complications in patients undergoing
oesophageal resection44. Despite its high sensi-
tivity, the specificity of the CPET is not high
enough to identify patients with a significant
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preoperative risk correctly, as patients with low
ATs can still undergo major surgery without
complications.
Risk of acute kidney injury (AKI). Approximately
1% of patients undergoing non-cardiac surgery
develop AKI, and it is associated with higher
morbidity and mortality. Eleven preoperative
risk factors (age 56 years or older, male sex,
emergency surgery, intraperitoneal surgery, dia-
betes mellitus necessitating oral therapy, dia-
betes mellitus necessitating insulin therapy,
active congestive heart failure, ascites, hyperten-
sion, mild preoperative renal insufficiency and
moderate preoperative renal insufficiency) have
been identified as independent predictors of
AKI in patients undergoing non-cardiac surgery.
The risk of developing postoperative AKI can
be stratified in five classes based on to the pres-
ence of these risks factors (General Surgery
Acute Kidney Injury Risk Index).45
Summary and recommendations: preoperative
scoring tools and functional capacity tests can
be used to identify patients at risk of complica-
tions and to stratify perioperative risk (Table 1).
Recommendation grade:
POSSUM: strong
Lee Index: strong
Cardiovascular Risk Calculator: strong
Walk tests: strong (to predict postoperative
morbidity, but not to decide if operate or not)
CPET: strong
General Surgery Acute Kidney Injury Risk
Index: strong
Optimization of pre-existing health conditions
Alcohol. Alcohol abusers (defined by the World
Health Organization as ingesting more than 36 g
of ethanol or equivalent of 3 standard drinks/
day) have an increased risk of perioperative
bleeding and wound infection. Furthermore,
alcohol impairs the metabolic stress response,
cardiac and the immune function. The risk
increases proportionately with the amount of
alcohol ingested with an increased perioperative
risk of 200–400% when ingestion exceeds 5
drinks or 60 g of ethanol per day. A minimum
of 4 weeks abstinence is needed to reduce these
risks, but 8–12 weeks may be needed for
patients to return to normal. However, it is often
a challenge to maintain abstinence in these
patients even with replacement medical therapy.
Patients with end stage liver failure due to cir-
rhosis are at extremely high risk and will need
expert care for all types of procedures46,47.
Smoking. Smokers often have comorbidities due
to smoking such as chronic obstructive airways
disease, emphysema, peripheral vascular and
ischaemic heart disease and cerebrovascular
Table 1 Scoring systems for surgery.
Test Predicting Scoring Evidence level Recommendation
P-POSSUM Mortality and Morbidity 12 physiological and 6 operative
variables
High Strong
Lees index Perioperative cardiac complications 6 preoperative clinical factors Moderate Strong
Cardiovascular Risk
Calculator
Myocardial Infarct or Cardiac Arrest 4 preoperative clinical factors and 1
operative variable
Moderate Strong
Shuttle Walk Test Perioperative complications Aerobic fitness Moderate Moderate
Shuttle Walk Test Screening tool to proceed to
CPET/echocardiography etc.
Aerobic fitness Moderate Strong
Cardiopulmonary Exercise
testing (CPET)
Perioperative complications Aerobic exercise – AT and VO2 max Moderate Strong
Cardiopulmonary Exercise
testing (CPET)
Selecting patient’s suitability for
surgery
Aerobic exercise – AT and VO2 max Moderate Moderate
General Surgery Acute
Kidney Injury Risk Index
Acute Kidney Injury 11 preoperative clinical factors Moderate Moderate
AT, anaerobic threshold; VO2, maximum oxygen consumption.
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disease that can increase the risk of periopera-
tive complications independently. Smokers
without these comorbidities still have an
increased perioperative risk, mainly due to poor
wound and tissue healing which can lead to
wound infection48 as well as cardiopulmonary
complications such as chest infection. Studies
have been undertaken to assess whether short-
term abstinence from smoking can improve out-
come. The cessation of smoking for 4 weeks
prior to surgery has been shown to improve
wound healing.48–50 The use of nicotine replace-
ment therapy (NRT) and counselling facilitate
preoperative smoking cessation.49 Other phar-
macological interventions are also available.
Varenicline, in combination with two preopera-
tive 15-minute standardized counselling ses-
sions, started 1 week before surgery and
followed up for 12 weeks, was shown to
improve long-term smoking abstinence (RR
1.45, 95% CI 1.01–2.07, P = 0.04) but not reduce
postoperative complications in comparison with
placebo. However, nausea occurred more fre-
quently in patients treated with varenicline
(13.3% vs. 3.7%, P = 0.004).51 Antidepressants
such as bupropion also seem beneficial to
improve smoking cessation, but limited data are
available in the perioperative setting.52,53
Preoperative anaemia. Haemoglobin is one of the
main determinants of oxygen delivery. Preopera-
tive anaemia is common and is an independent
predictor of mortality and postoperative compli-
cations.54,55 Haemoglobin levels should be cor-
rected preoperatively, as it is common to expect
a drop of haemoglobin concentrations due to
blood loss and to the dilution effect of intra-
venous fluids. Correction of preoperative anae-
mia should take in consideration its
aetiology.56,57 Iron, folate, vitamin B12 supple-
ments and/or erythropoietin should be used
when appropriate. Medical management of pre-
operative anaemia takes time and should be
planned at least 3–4 weeks before elective sur-
gery. Although preoperative blood transfusion
corrects anaemia rapidly and could be used in
severely anaemic patients and/or in patients
undergoing surgery with expected profound
blood loss, caution should be used as it has
been associated with increased mortality and
morbidity.58–60 These effects seem to be dose-
dependent.58 The risk of transfusion-related
complications and the effect of blood transfusion
on the immune system must be also consid-
ered.56,57,61 Evidence suggesting that normaliz-
ing preoperative haemoglobin levels prior to
surgery reduces postoperative morbidity and
mortality is lacking and studies evaluating the
role of preoperative anaemia optimization are
warranted.57,62 Implementation of perioperative
blood management protocols can reduce the risk
of allogenic blood transfusions.56,57
Cardiovascular risk reduction. It is not the intent of
this manuscript to discuss in detail periopera-
tive cardiovascular strategies to reduce cardio-
vascular risk. These interventions are
extensively discussed in the recent ACC/AHA
2014 guidelines.30
Asthma, COPD and diabetes. Chronic conditions
such as asthma, chronic obstructive airways dis-
ease63, diabetes mellitus64 malnutrition65–67 and
frailty68 should be optimized prior to surgery.
Summary and recommendation: cessation of
smoking and alcohol intake at least 4 weeks
before surgery is recommended. Encouraging
patients is not enough; pharmacological support
and individual counselling should be offered to
every patient who smokes and to alcohol abu-
sers undergoing elective surgery. Optimization
of medical conditions, such as cardiovascular
diseases, anaemia, chronic obstructive airways
disease, diabetes, nutritional status and frailty
and should follow international recommenda-
tions.
Recommendation grade:
Smoking cessation: high
Nicotine replacement therapy and counselling:
high
Alcohol cessation: low
Medical optimization: strong
Pre-anaesthetic medications
Patients undergoing major surgery are, as
expected, anxious. Anxiety has also been shown
in many studies to be the most common predic-
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tor for postoperative pain and positively corre-
lates with postoperative pain intensity.69 Fur-
thermore, preoperative pain is also a significant
predictor for postoperative pain.70 Therefore,
education and counselling, and preoperative
analgesic and anxiolytic medication must be
specifically addressed during the preoperative
assessment of the patient. Short-acting anxiolyt-
ics and analgesics can be administered to facili-
tate regional anaesthetic procedures and
insertion of intravascular lines, provided they
are used in adequate doses based on age and
patients’ comorbidities.71 Short-acting benzodi-
azepines should be avoided in older patients
(age > 60).72 Long-acting sedatives and opioids
should be avoided as they may hinder recovery,
thus impairing postoperative mobilization and
direct participation, resulting in prolonged
length of stay.71
Summary and recommendation: long-acting anxi-
olytic and opioids should be avoided as they
may delay discharge. Short-acting benzodi-
azepine should be avoided in the elderly.
Recommendation grade: strong
Preoperative fasting and carbohydrate loading
Although fasting guidelines of various anaesthe-
sia societies support the safety of allowing clear
fluids up to 2 h and solid food up to 6 h before
the induction of anaesthesia, patients scheduled
for elective surgery are commonly asked to fast
from midnight. The evidence supporting this
practice, with the belief to ensure an empty
stomach before the induction of anaesthesia and
decrease the risk of aspiration is lacking.73 On
the contrary, it has been shown that fasting from
midnight increases insulin resistance, patient’s
discomfort and potentially decreases intravascu-
lar volume, especially in patients receiving
mechanical bowel preparation.74 In fact, func-
tional intravascular deficit after fasting time, as
indicated by guidelines75 or after 8 h fasting76 is
minimally affected in patients undergoing
elective surgeries without mechanical bowel
preparation.75,76 Results from two Cochrane
meta-analyses have shown that gastric content
of patients following anaesthesia fasting guide-
lines is the same or lower of the gastric content
of patients fasting after midnight.77,78 Imaging
studies have further supported the safety of
allowing clear fluids up to 2 h before the induc-
tion of anaesthesia, showing complete gastric
emptying with 90 min.79 Recently, the Euro-
pean and American Anesthesia Society have
revised their fasting guidelines and have not
changed their previous recommendations.80,81
Preoperative treatment with oral complex carbo-
hydrates (CHO) (maltodextrin) with a relatively
high concentration (12.5%), with 100 g
(800 ml) administered the night before of sur-
gery and 50 g (400 ml) 2–3 h before induction
of anaesthesia, reduces the catabolic state
induced by overnight fasting and surgery.
Indeed, overnight fasting before surgery inhibits
insulin secretion and promotes the release of
catabolic hormones such as glucagon and corti-
sol. By increasing insulin levels preoperative
treatment with oral CHO reduces postoperative
insulin resistance, maintains glycogen reserves,
decreases protein breakdown and improves
muscle strength.82 Faster surgical recovery and
better postoperative well-being still remains
controversial83,84. Delayed gastric emptying
should be suspected in patients with docu-
mented gastroparesis, patients on prokinetic
agents such as metoclopramide and/or domperi-
done, patients scheduled for gastrointestinal
operations such oesophageal, gastric, fundopli-
cation, paraesophageal hernia repair, gastro-jeju-
nostomy, in patients who underwent previous
Whipple’s procedure, in patients with achalasia
and in patients with neurological diseases with
dysphagia. Patients with diabetes with neuropa-
thy and, less clearly, obese patients85 are con-
sidered to have delayed gastric emptying.
However, gastric emptying after 300 ml of clear
fluids 2–3 h before the induction of anaesthesia
in obese patients has been shown to be similar
to those of lean patients86,87 and gastric empty-
ing after CHO administration in patients with
uncomplicated diabetes is normal.88,89 The clini-
cal relevance of preoperative CHO drinks in
these specific populations remains to be estab-
lished.
Summary and recommendation: Intake of clear
fluids should be allowed until 2 h before induc-
tion of anaesthesia. Solids should be allowed
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until 6 h. Preoperative treatment with oral
CHOs can be administered safely except in
patients with documented delayed gastric emp-
tying or gastrointestinal motility disorders and
as well in patients undergoing emergency sur-
gery.
Recommendation grade:
Adherence to fasting guidelines (avoid over-
night fasting): strong
Administration of preoperative CHOs: strong
Administration of preoperative CHOs in dia-
betic and obese patients: weak
Part B. Intraoperative and postoperative ERAS
elements
Preventing and treating postoperative
nausea and vomiting
Despite significant advances in our knowledge
of PONV and the introduction of new agents,
the overall incidence of PONV is currently esti-
mated to be 20–30%. In high-risk patients, the
incidence in still as high as 70%,90 and it is one
of the most unpleasant experiences in the peri-
operative period.91
There are many risk factors that predispose
patients to PONV.92 The most widely used scor-
ing system was developed by Apfel et al.,93
who created a simplified scoring system using
only four risk factors – female gender, a history
of motion sickness or PONV, non-smoking sta-
tus and the use of postoperative opioids.92
The multimodal approach to PONV within an
ERAS programme contains the use of antiemet-
ics and a total intravenous anaesthesia with
propofol instead of inhalational agents. Avoid-
ance of nitrous oxide is also important.94 Other
factors like the reduction of preoperative fasting,
carbohydrate loading and adequate hydra-
tion95,96 and high inspired oxygen concentra-
tions97 may influence the prevalence of PONV.
The use of regional anaesthetic techniques and
the use of non-steroidal anti-inflammatory drugs
(NSAIDs) as opioid-sparing strategies may have
an additional indirect influence on the preva-
lence of PONV.
Classes of antiemetics (serotonergic, dopamin-
ergic, cholinergic and histaminergic) are based
on the antagonism of different kinds of central
receptors that are all involved in the pathophys-
iology of PONV and all have shown to be supe-
rior to placebo in the prevention of PONV.98
Newer drugs as the neurokinin-1 receptor antag-
onists show encouraging results in initial tri-
als.99 Unfortunately, none of the available
pharmacological agents when used alone are
effective in reducing the incidence of PONV by
more than 25%. Antiemetic combinations are
recommended for patients at higher risk of
PONV. Combination therapy is more effective
than monotherapy, and for high-risk patients,
combination with 2–3 antiemetics in addition to
propofol based total intravenous anaesthetic
(TIVA) has the greatest likelihood of reducing
PONV.
Examples of antiemetic drugs are serotonin
antagonists like ondansetron 4 mg i.v. or dopa-
mine antagonists like droperidol 0.625–1.25 mg
i.v. given at the end of surgery or a transdermal
patch of scopolamine placed the evening prior to
or 2 h before surgery. Dexamethasone 4–5 mg i.v.
after induction of anaesthesia has also been
shown to be effective, but its immunosuppressive
effects on long-term oncological outcome are
unknown. Higher doses of dexamethasone have
no additional effect and are associated to sleep
disturbances. It should not be used in diabetic
patients requiring insulin and not given prior to
induction of anaesthesia due to perineal pain.
If PONV is present postoperatively, rescue
therapy should be with an antiemetic from a
different class unless the elapsed time from the
previous antiemetic administration is greater
than 6 h,100 After prophylactic administration of
4 mg ondansetron re-dosing for established
PONV was shown to be no more effective than
placebo.101
Summary and recommendation: Aggressive PONV
prevention strategy should be included in an
ERAS protocol.102 All patients with 1–2 risk fac-
tors should receive as PONV prophylaxis a com-
bination of two antiemetics. Patients with 3–4
risk factors should receive 2–3 antiemetics and
total intravenous anaesthesia (TIVA) with
propofol and opioid-sparing strategies should
be encouraged.93,102
Recommendation grade: strong.
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Standard anaesthetic protocol and depth of
anaesthesia monitoring
Although there are no studies comparing gen-
eral anaesthetic techniques for gastrointestinal
surgery, it is sensible to assume that within the
ERAS protocol efforts have to be made to mini-
mize the impact of anaesthetic agents and tech-
niques on organ function, and to facilitate rapid
awakening from anaesthesia thus accelerating
recovery of the patient’s gastrointestinal and
motor functions. As such particular attention
can be drawn to the type of agents used and the
monitoring of vital functions.
Traditionally the anaesthesiologist has relied
on clinical signs to try and ensure appropriate
depth of anaesthesia and avoidance of awareness
but also avoiding overdose and the resultant
depression of a patient’s physiological status.
Depth of anaesthesia can now be measured by
many devices but in terms of clinical evaluation
the data on Bispectral Index (BIS) far exceeds
other devices.103 Recent focus has been on using
depth of anaesthesia monitoring not just to avoid
awareness during surgery but also to titrate the
minimum amount of anaesthetic necessary to
avoid complications.103–116 This appears to have
particular significance in the elderly population
with cognitive dysfunction.117 Unfortunately BIS
is not infallible. Many things can affect the BIS
value, in particular neuromuscular relaxation,
which is commonly used in anaesthesia. The
specificity seems to be lower when using total
intravenous anaesthesia (TIVA).106 There is also
a lag time between EEG interpretation and the
displayed BIS value.
When compared with clinical signs alone, BIS
obtains lower rates of awareness during
surgery.112–114,116 Anaesthetic depth guided by
BIS may also help reduce the amount of drug
given,107,116 with more rapid immediate recovery
although the time to discharge home appears to
be unaffected116. In Myles’ study, 138 patients
needed to have BIS monitoring to avoid one case
of awareness.112 Avidan’s studies104,105 have
demonstrated that maintaining anaesthetic depth
with an end tidal concentration (EATC) between
0.7 and 1.3 MAC equivalents can prevent intra-
operative awareness as effectively as anaesthesia
guided by a BIS value between 40 and 60. The
use of nitrous oxide, a N-methyl-D-aspartate
(NMDA) receptor antagonist, has been shown to
reduce the risk of awareness118 with one study
showing an NNT of 46,119 however, there were
two cases of awareness in the ENIGMA study in
patients having nitrous oxide.120 Recent studies
have highlighted that patients with BIS levels
< 45 under anaesthesia (reflecting increased sup-
pression of brain activity) have an increased risk
of death by up to 1.24-fold (95% CI 1.06–
1.44).121 Subsequent analysis suggests this may
be a reflection of elderly patients who have mul-
tiple problems and cognitive dysfunction and
may have a reduced life expectancy prior to sur-
gery more likely to have low BIS values. More
studies are needed to clarify this point. There is
increasing interest in anaesthetic drugs and anal-
gesic techniques. (e.g. morphine and thoracic
epidural analgesia) and their effect on cancer
outcome but there is currently not enough con-
sistent data to support making specific recom-
mendations.122,123
Summary and recommendation: anaesthetic depth
should be guided either maintaining an end
tidal concentration of 0.7–1.3 MAC or BIS index
between 40 and 60 with the aim not only to
prevent awareness but also to minimize anaes-
thetic side effects and facilitate rapid awakening
and recovery. Avoid too deep anaesthesia (BIS
< 45), especially in elderly patients
Recommendation grade: strong
Neuromuscular blockade (NMB) and
neuromuscular monitoring
This section discusses the importance of neuro-
muscular blockade and neuromuscular monitor-
ing, and their potential implications specifically
in the context of an ERAS programme. Neuro-
muscular blockade agents (NMBA) paralyse
skeletal muscles, allowing optimal conditions
for surgery. The level of NMB needed to obtain
optimal surgical conditions can differ depending
on the surgical approach. A deep NMB might be
particularly useful when a laparoscopic
approach is used.124,125 A recent systematic
review showed that during certain laparoscopic
procedures deep NMB (e.g. Post-Tetanic Count
1 or more; but Train of Four (TOF) Count of
0126) provide better surgical conditions than
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moderate NMB125, but limited evidence is avail-
able to support this practice.126 Moreover, the
use of deep NMB during laparoscopic proce-
dures, especially in countries where sugam-
madex is not available, may increase the risk of
residual paralysis.126 Although moderate NMB
certainly facilitates surgical work, the use of
NMB might not be always necessary for patients
undergoing open abdominal surgery. Indeed, an
adequate level of anaesthesia without muscle
relaxants can produce a good to excellent surgi-
cal field in approximately two-third of patients
undergoing radical retropubic prostatectomy.127
In the light of these considerations, the
hypotheses that optimal NMB can potentially
attenuate surgical stress by shortening the dura-
tion of surgery, and that it can facilitate the use
of low pneumoperitoneum pressures, thereby
reducing postoperative pain remain appealing,
especially in the context of an ERAS pro-
gramme. However, this needs to be tested in lar-
ger high-quality trials.
At the end of surgery, it is important to
restore neuromuscular function to preoperative
levels and avoid residual muscle paralysis
which can be responsible for respiratory insuffi-
ciency, hypoxia, aspiration into the lungs as
well as distress for the patient.128 Similarly, it
might impair early mobilization. To avoid resid-
ual muscle paralysis long-acting NMBA should
not be used.128 Hypothermia also influences
neuromuscular function directly and prolongs
duration of action and recovery time of NMBA
significantly.129 Maintenance of normothermia
is, therefore, essential to prevent residual paral-
ysis.129
The use of NMBA must be guided by ade-
quate assessment of neuromuscular block and
appropriate monitoring. In healthy volunteers, it
has been demonstrated that there is risk of pha-
ryngeal dysfunction or aspiration if TOF
< 0.9.130 Furthermore, three clinical trials131–133
have demonstrated that there is a greater pro-
portion of hypoxaemic events and prolonged
stay in the recovery room if TOF < 0.9. Even
more experienced anaesthesiologists cannot clin-
ically identify the degree of residual curariza-
tion.134 Several studies have shown that clinical
tests and qualitative (visual or tactile) assess-
ment of neuromuscular function (TOF, double
burst suppression or tetanic stimulation) are not
reliable and sufficient to detect residual
curarization,128 even when sugammadex is
used.135 Quantitative methods such as
mechanomyography and acceleromyography
provide more accurate information.136 Although
mechanomyography remains the goal-standard
to measure neuromuscular function, its use in
clinical practice remains limited136. On the con-
trary, acceleromyography can be used easily to
measure neuromuscular function and avoid
residual paralysis.136
There are three ways to avoid residual paraly-
sis:
1. Waiting for a spontaneous recovery of neuro-
muscular function identified by a TOF>0.9.
This approach might not be convenient for
brief surgical procedures, as the effect of
some NMBA can last longer than 4 h, even
after a single dose administered at the begin-
ning of surgery.137 Side effects of reversal
agents are avoided.
2. Administering cholinesterase inhibitors. Side
effects of cholinesterase inhibitors and
antimuscarinic agents have to be considered.
3. Administering sugammadex. Sugammadex
selectively revers the neuromuscular block
induced by steroidal NMBA. Abrishami et al.
demonstrated that sugammadex reverses neu-
romuscular block (rocuronium-induced) fas-
ter than neostigmine and independent of the
depth of the neuromuscular block.138 Sugam-
madex can be used at different dosages, 2, 4
or 16 mg/kg to reverse moderate, deep or
recently induced block, respectively. Sugam-
madex reverses neuromuscular block 3–4
times faster than neostigmine, and the neuro-
muscular block is completely reversed after
5 min.
Summary and recommendations: It remains con-
troversial if deep neuromuscular blockade dur-
ing laparoscopic surgery improves operating
conditions. Neuromuscular function should be
always monitored when using NMBA to avoid
residual paralysis. Long-acting NMBA should
be avoided. When NMBA are administered neu-
romuscular function should be monitored by
using a peripheral nerve stimulator to ensure
adequate muscle relaxation during surgery and
optimal restoration of neuromuscular function at
Acta Anaesthesiologica Scandinavica 60 (2016) 289–334
298 ª 2015 The Authors. Acta Anaesthesiologica Scandinavica published by John Wiley & Sons Ltd on behalf of Acta Anaesthesiologica Scandinavica Foundation
A. FELDHEISER ET AL.
the end of surgery. A TOF ratio of 0.9 must be
achieved to ensure adequate return of muscle
function and thus preventing complications.
Recommendation grade: Monitoring neuromuscu-
lar function: strong.
Reversing neuromuscular blockade: strong.
Use of inspired oxygen
Oxygen is a highly reactive gas which is ubiqui-
tous in anaesthetic practice. In cellular physiol-
ogy the controlled oxidation of glucose to
carbon dioxide with the concurrent reduction of
oxygen to water is the basis for aerobic metabo-
lism and production of energy. Therefore, one of
the highest priorities of the anaesthesiologist is
to try to ensure a patient does not become
hypoxic to avoid interruption of cellular
metabolism.
Oxygen is widely available in anaesthesia and
has traditionally been added to increase the
inspired fraction of oxygen above 21% to over-
come hypoxia under anaesthesia caused by
physiological changes such as pulmonary shunt.
Although increasing the FiO2 is necessary to
overcome hypoxia there has been increasing
recognition that hyperoxia can cause damage
due to the production of oxygen free radicals.
However, it has been suggested that high
inspired oxygen concentration protects against
the risk of surgical site infections. The PROXI
trial, a multicentre RCT, found no differences
between patients treated with a FiO2 30% vs.
80% in terms of SSI or pulmonary complica-
tions.139.A meta-analysis including the PROXI
trial showed that two subgroups of patients
benefitted from high inspired oxygen therapy –
those undergoing general anaesthesia and col-
orectal surgery.140 However a high-heterogene-
ity was found among the studies included.140
The latest meta-analysis including new nine
RCTs (5001 patients) found a marginal reduc-
tion of SSI in patients undergoing colorectal
surgery treated with high concentrations of oxy-
gen vs. normal oxygen concentrations (RR 0.77,
95% CI 0.59–1.00, P = 0.03). The study also
found that high oxygen concentrations reduce
the incidence of late (24 h postoperatively) nau-
sea and vomiting, but only in patients receiving
volatile anaesthesia without antiemetic prophy-
laxis.97 Based on these data, it still remains
unclear if high concentrations of oxygen protects
against the risk of SSI.
On the con side was the long-term follow-up
of patients included in the PROXI trial. This
study showed a reduction in survival in patients
with cancer who had received the higher
inspired oxygen concentration.141 Unfortunately,
the authors failed to report why patients died
earlier than patients receiving normal inspired
oxygen concentrations. Both this study and the
analysis of outcomes of patients following car-
diac arrest, which show a poorer neurological
outcome in patients receiving a higher
FiO2,
142,143 suggest that there can be harmful
effects from receiving high inspired concentra-
tions of oxygen.
Therefore, higher inspired oxygen concentra-
tions of 80% may reduce surgical wound site
infection especially in patients with colorectal
cancer, but there may be deleterious effects on
long-term cancer outcomes. To reduce wound
infection to a minimum the importance of other
contributing factors such as maintaining
patient’s body temperature, cardiac output, gly-
caemic control, prophylactic antibiotics and
minimizing surgical contamination should also
be considered.
The short-term use of high inspired oxygen
concentrations is widely practised in anaesthesia
to overcome hypoxic episodes and to pre-oxyge-
nate (de-nitrogenate) the lungs prior to the
induction of anaesthesia. Edmark and colleagues
looked at differing inspired concentrations
(60%; 80%; 100%) of oxygen for 5 min prior to
the induction of anaesthesia.144 Computed
tomography showed an increase in atelectasis in
the 100% inspired oxygen group although
patients took longer to desaturate. The use of
80% oxygen in a subgroup of the PROXI study
and in a recent meta-analysis also did not
demonstrate any increased risk of pulmonary
complications.97,145
Summary and recommendations
1). The inspired fractional concentration of oxy-
gen should be titrated to produce normal
arterial oxygen levels and saturations. Pro-
longed periods of high inspired oxygen con-
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centrations which result in hyperoxia should
be avoided.
Recommendation grade: strong
2).100% inspired oxygen concentrations can be
used for pre-oxygenation prior to anaesthesia
or for short periods to overcome hypoxia.
Recommendation grade: strong
Preventing intraoperative hypothermia
Perioperative hypothermia, defined as a core
temperature below 36°C is a common adverse
consequence of anaesthesia and surgery.146 The
prevalence of inadvertent hypothermia ranges
from 50% to 90%147 independently whether
patients undergo laparoscopic or open sur-
gery.148 Older adults are more prone to heat
loss, whereas obesity has a protective effect.149
Hypothermia in most patients undergoing
general anaesthesia is the result of an internal
core-to-peripheral redistribution of body heat
that usually reduces core temperature by 0.5–
1.5°C in the first 30 min after induction of
anaesthesia.150
Several meta-analyses and RCTs have demon-
strated that preventing inadvertent hypothermia
during major abdominal surgery significantly
reduces wound infections,151,152 cardiac compli-
cations,151,153 bleeding and transfusion require-
ments,153,154 and improves immune function,151
the duration of post-anaesthetic recovery155 and
overall survival.156 Therefore, it makes sense to
prevent the loss of body heat as also recom-
mended by the ERAS society.
Use of active warming devices is highly rec-
ommended in all cases lasting more than
30 min151 and this can be achieved by using
different warming devices (forced air warming
systems, circulating water garments or warmed
i.v. solutions). Combined strategies, and among
the others preoperative warming, should be con-
sidered in vulnerable groups such as older
patients with cardiorespiratory diseases, and
surgery of long duration.147 Rewarming should
be performed to a core temperature of 35.5–
36.0°C before emergence from anaesthesia, and
every effort should be made to avoid shivering
by using meperidine 0.25–0.5 mg/kg. Alterna-
tively clonidine 1–2 lg/kg i.v. can be used.
Summary and recommendation: Intraoperative
hypothermia should be avoided by using active
warming devices.
Recommendation grade: strong.
Surgical techniques
The short-term benefits of laparoscopic vs. open
surgery for abdominal surgery have been well
established in the literature to date and include
shorter length of stay, reduced postoperative
morbidity, earlier passage of flatus and less nar-
cotic analgesic requirements.157 However, long-
term outcomes have shown equivalence
between laparoscopic and open surgery.158 The
fact that laparoscopic practice has improved
since these trials were initiated, further consoli-
dates the role played by this technique as the
preferable one for abdominal surgery. In the
context of an enhanced recovery programme, the
multicentre randomized LAFA study has shown
positive benefits when laparoscopic resection is
optimized within an ERAS protocol.5
The main goal of enhanced recovery strategy
should not be based on the choice of laparo-
scopic vs. open, but less surgical invasiveness as
the surgical technique should minimize wound
trauma, tissue distraction and bleeding.
A recently updated Cochrane review compar-
ing transverse with midline laparotomy incisions
for abdominal surgery found less postoperative
opiate analgesic use with transverse incisions159
but no differences in visual analogue pain scores
reported by patients. Pooled data for spirometry
after the operation showed that a transverse inci-
sion had less effect on vital capacity and FEV1.
However, these benefits on pulmonary function
did not result in reduced pulmonary complica-
tions or hospital stay. A trend towards a lower
incidence of wound dehiscence was shown in the
transverse incision group. Finally there was a
reduction in incisional hernias with transverse
incisions, but the studies showed a high variety
of time to follow-up.
A number of new minimally invasive surgical
technologies have emerged over the past decade.
A recent meta-analysis of non-randomized con-
trolled trials has indicated that robotic total
mesorectal excision (TME) did not reduce opera-
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tion time, length of hospital stay, time to resume
regular diet, postoperative morbidity or mortal-
ity160 and is a technique that requires evaluation
through high-quality randomized research.
While single-incision laparoscopic resections
may improve recovery, no robust data have yet
appeared and these techniques are at an early
stage in their development.161 Furthermore,
transvaginal and transrectal specimen extraction
to avoid abdominal wounds has been described,
but with little data on short- and long-term
results.162,163 At this stage, no recommendation
can be made on these procedures. However, the
negative intraoperative pathophysiological con-
sequences (e.g. head-down-position, longer
operation time) have to be balanced to the bene-
fits of the minimal-invasive approaches and the
use of an ERAS protocol.
Summary and recommendation: Laparoscopic sur-
gery for gastrointestinal resections is recom-
mended when the expertise is available.
Transverse incisions for colonic resections
should be preferred.
Recommendation grade:
Laparoscopic approach: strong;
Transverse incisions: low.
Nasogastric intubation
There is strong evidence that routine nasogastric
decompression following elective laparotomy
should be avoided.164 Prophylactic nasogastric
tubes placed during surgery (to evacuate air)
should be removed before reversal of anaesthe-
sia. Fever, oropharyngeal and pulmonary com-
plications are more frequent in patients with
nasogastric tubes.164–166 Even death and other
serious complications resulting from nasogastric
tubes are reported.167,168 Avoidance of nasogas-
tric decompression is associated with an earlier
return of bowel function164–166,169 while gastroe-
sophageal reflux is increased during laparotomy
if nasogastric tubes are placed.170 Even in gas-
troduodenal and pancreatic surgery, there
appears to be no evidence of a beneficial effect
from the prophylactic use of nasogastric
tubes.164,171 However, the incidence of vomiting
has been shown to be higher in patients with-
out nasogastric tubes.164–166 Nevertheless, the
benefits of routinely avoiding nasogastric intu-
bations overcome the risks.
Delayed gastric emptying can occur in a small
proportion of patients, leading to vomiting and
fatal aspiration if not treated promptly by insert-
ing a nasogastric tube.172,173 The recognition
and avoidance of this complication is essential.
Teams should be taught to positively identify
these changes, particularly when patients are
failing to progress between 2 and 5 days after
surgery.
Summary and recommendation: Prophylactic use
of nasogastric tubes is not recommended for
patients undergoing elective colorectal surgery,
while its use in patients undergoing gastrec-
tomy and oesophagectomy is still debatable.
Patients with delayed gastric emptying after sur-
gery should be treated by inserting a nasogastric
tube.
Recommendation grade: strong.
Intraoperative glycaemic control
Blood glucose levels increase during and after
elective surgery with the magnitude of hyper-
glycaemia depending upon the patient’s meta-
bolic state (fasting, fed, diabetes), the type of
anaesthesia and analgesia and the severity of
surgical tissue trauma.174
Strong evidence indicates that even moderate
increases in blood glucose are associated with
adverse outcomes.175–177 Patients with fasting
glucose levels > 7 mmol/l or random blood glu-
cose levels > 11.1 mmol/l on general surgical
wards showed an 18-fold increased in-hospital
mortality.175
More recent observations suggest that the
quality of preoperative glycaemic control also is
important. In fact elevated HbA1c levels have
been found to be predictive of complications
after cardiac and abdominal surgery.178–181
Mere associations between two variables, i.e.
glycaemia and clinical outcomes, do not prove a
direct cause–effect relationship. At present there
is insufficient evidence to demonstrate superior-
ity of strict glycaemic control (blood glucose
levels within a normal and narrow range) over
conventional management in surgical patients.
As in the ICU situation, it remains a balance
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between the benefits of bringing down glucose
levels vs. the risks of hypoglycaemia. For the
surgical patient on the ward, there is also the
issue of the nursing staffing and their capacity
to monitor patients on intensive insulin treat-
ment to take into account. A review of the effect
of glycaemic control on the incidence of surgical
site infections was inconclusive, mainly because
of the small number of studies (n = 5), the
heterogeneity in patient populations, the route
of insulin administrations, the definition of out-
comes measures and the fact that glycaemic tar-
gets were different and/or were not achieved.182
Hence, to date, the optimal glucose level for
enhancing clinical outcomes is unknown.
This uncertainty is reflected by the diversity of
recommendations issued by Medical Associa-
tions concerning blood glucose control in criti-
cally ill and surgical patients.64,183–185 Overall
most of the Associations recommend treatment
of random blood glucose concentrations
> 10 mmol/l. A large randomized controlled trial
of aggressive preservation of normoglycaemia vs.
conventional glycaemic control is necessary to
identify target blood glucose concentrations in
patients undergoing major surgery.
In the meantime, it is important to emphasize
that there are a range of elements in the ERAS
protocol that will reduce insulin resistance and
hence reduce the risk of hyperglycaemia and
that should be employed.186 These include pre-
operative carbohydrates, an active mid thoracic
epidural, early feeding and good pain control.
Summary and recommendation: Glucose concen-
trations should be kept as close to normal as
possible without compromising safety. Employ-
ing perioperative treatments that reduce insulin
resistance without causing hypoglycaemia is
recommended.
Recommendation grade: strong.
Perioperative haemodynamic management
Preoperative period: preoperative hydration deficit
can vary according to patients’ comorbidities,
preoperative fasting and use of preoperative
mechanical bowel preparation (MBP). The
avoidance of prolonged preoperative fasting,80,81
MBP187,188 and as well the administration of
preoperative carbohydrate (CHO) drinks83 have
substantially reduced intraoperative fluid
requirements. However, when MBP is indicated
fluid and electrolytes derangements occur even
if patients are encouraged to drink.74,189,190 The
replacement of preoperative intravascular defi-
cits should be based on individualized intraop-
erative fluid administration strategies75 rather
than administering fluid based on anecdotal
“textbook recipes”.
Intraoperative period: intraoperative fluid ther-
apy aims to administer balanced crystalloid
solutions to cover the needs derived from the
salt–water homoeostasis. This is in contrast to
volume therapy where goal-directed boluses of
intravenous solutions are administered to treat
objective evidence of hypovolaemia, and conse-
quently improve intravascular volume and cir-
culatory flow.
Intraoperative fluid therapy should aim to
maintain a near-zero fluid balance191 and substan-
tial weight gain of more than 2.5 kg should be
avoided.192. Intraoperative fluid requirements can
be met with a basal crystalloid infusion rate of
3  2 ml/kg/h (also called restrictive app-
roach11).192–194 Crystalloid excess increases the
risk of pulmonary complications,193 prolonged
ileus192,195,196 and delayed recovery.197
Crystalloid isotonic balanced solutions should be
preferred and 0.9% saline solutions avoided.198,199
Hyperchloraemia caused by the use of 0.9% saline
solutions has been associated with kidney dysfunc-
tion200–202, prolonged hospital stay and increased
30-daymortality (OR = 1.58, 95%CI 1.25–1.98).200
Intraoperative volume therapy should be per-
formed by bolus administration of an intra-
venous solution based on objective measures of
hypovolaemia. Goal-directed fluid therapy
(GDFT) aims to maintain central normovolaemia
by utilizing changes in stroke volume measured
by a minimally invasive cardiac output monitor
to optimize the patients on their individual
Frank–Starling curve.96,203
Trans-oesophageal Doppler (TOD)-guided
GDFT has been shown to reduce the length of
hospital stay and postoperative complications in
several RCTs of patients undergoing non-cardiac
surgery96,204–206 and in a hospital quality
improvement project.207 Similarly, GDFT based
on pulse contour analysis and aiming to mini-
mize stroke volume variations during the respi-
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ratory cycle of mechanically ventilated patients
has also shown to decrease morbidity and accel-
erate recovery203,208–210. These findings are in
agreement with the results of 2 recent meta-ana-
lysis209,211.
However, the benefits of GDFT seem to be off-
set by the optimization of perioperative surgical
care. In fact, in two recent RCTs, TOD-guided
GDFT showed no benefits on postoperative out-
comes in low-risk patients treated within an
ERAS protocol.191,212. These results could be
also explained by a judicious fluid management
in patients not treated with GDFT, as the
amount of intravenous fluid received in patients
randomized in these patients was significantly
less than the amount received by the same pop-
ulation in previous studies.213
The benefits of GDFT become more clinically
meaningful in high-risk patients214,215, and in
patients undergoing surgery associated with lar-
ger intravascular fluid loss (blood loss and pro-
tein/fluid shift)213,216. In the largest multicentre
RCT (734 patients), Pearse et al. found a non-
significant trend towards decreased complica-
tions (36% vs. 43.4% respectively, P = 0.07) and
180-day mortality (7.7% vs. 11.6% respectively,
P = 0.08) in high-risk patients receiving GDFT
compared with patients receiving usual care.215
Auditing internal data (amount of intraoperative
fluid given, surgical loss, complications,
mortality, length of stay and readmission rate) is
essential to determine if GDFT should be imple-
mented as routine strategy to improve postoper-
ative outcomes.213
Colloidal solutions have been mainly used to
optimize stroke volume during GDFT.96,204–206
Colloids improve circulatory flow to a greater
extent,217,218 produce better blood volume
expansion and less interstitial space overload
than crystalloids219 and could reduce the inci-
dence of postoperative nausea and vomiting and
postoperative pain.220 Recently, Yates et al.
showed that in moderate–high-risk patients
GDFT with colloid boluses does not accelerate
the recovery of bowel function, reduce compli-
cations or impair haemostasis compared with
crystalloids.221 Recent data have suggested that
the use of large volumes of colloids adminis-
tered post-resuscitation in critically ill patients
can increase the risk of death and acute kidney
injury (AKI) in critically ill patients,222,223 but
these results have not been consistently repro-
duced in the perioperative setting.224,225 A
recent study has found a dose-dependent associ-
ation between the volume of HES administered
and the development of AKI. The Pharmacovigi-
lance Risk Assessment Committee of the Euro-
pean Medicines Agency has recommended that
HES should only be used for the treatment of
hypovolaemia caused by acute blood loss when
crystalloids alone are not considered sufficient
and that it should be used at the lowest effec-
tive dose for the shortest period of time. It also
states that treatment should be guided by con-
tinuous haemodynamic monitoring so that the
infusion is stopped as soon as appropriate
haemodynamic goals have been achieved. The
committee also observed that there is a lack of
robust long-term safety data in patients under-
going surgical procedures and in patients with
trauma.226 Moreover, the use of large volumes
of colloids (2605  512 ml) hydroxyethyl starch
(HES) 130/0.4 during major urological proce-
dures has shown to impair haemostasis and
increase surgical blood loss compared with crys-
talloids.227 Nevertheless, crystalloid-based
GDFT can significantly increase the risk of fluid
overload.227
Arterial hypotension should be treated with
vasopressors when administering intravenous
fluid boluses fails to significantly improve the
stroke volume (stroke volume > 10%).13,203
Inotropes should be considered in patients with
reduced contractility (Cardiac Index < 2.5 l/min)
to guarantee adequate oxygen delivery.203
Postoperative period. Early oral intake of fluids
and solids following abdominal surgery should
be encouraged171,228,229. If oral intake is toler-
ated, routine intravenous fluid administration
should be discontinued after PACU discharge
and restarted only if clinically indicated. In the
absence of surgical losses to cover physiological
needs patients should be encouraged to drink
25–35 ml/kg of water per day (1.75–2.75 l for an
average person).11 After ensuring the patient is
normovolaemic, hypotensive patients receiving
epidural analgesia should be treated with vaso-
pressors.230,231
Summary and Recommendation: The goal of peri-
operative fluid therapy is to maintain fluid
homeostasis avoiding fluid excess and organ
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hypoperfusion. Fluid excess leading to perioper-
ative weight gain more than 2.5 kg should be
avoided, and a perioperative near-zero fluid bal-
ance approach should be preferred. The need of
GDFT should be determined based on clinical
and surgical factors. GDFT should be adopted
especially in high-risk patients and in patients
undergoing surgery with large intravascular
fluid loss (blood loss and protein/fluid shift).
Inotropes should be considered in patients with
poor contractility CI < 2.5 l/min). 0.9% saline
and saline-based solutions should be avoided,
with balanced solutions preferred. Colloids
should be used to treat objective evidence of
hypovolaemia. In patients receiving epidural
analgesia, arterial hypotension should be treated
with vasopressors after ensuring the patient is
normovolaemic. In the absence of surgical
losses, postoperative intravenous fluid should
be discontinued and oral intake (1.5 l/day)
encouraged.
Recommendation grade: GDFT: Strong in high-
risk patients and for patients undergoing sur-
gery with large intravascular fluid loss (blood
loss and protein/fluid shift)
GDFT: low in low-risk patients and in
patients undergoing low-risk surgery
Perioperative near-zero fluid balance: moderate
Use of advanced haemodynamic monitoring:
strong in high-risk patients and for patients
undergoing surgery with large intravascular
fluid loss (blood loss and protein/fluid shift)
Balanced crystalloids vs. 0.9% saline
Healthy volunteer studies have suggested that
the excretion of an acute saline load is slower
when compared with balanced crystalloid infu-
sions232–234, and saline tends to overload the
interstitial space to a greater extent, with a ten-
dency to result in more oedema than balanced
crystalloids.232 Mechanisms for excreting this
saline excess are inefficient, depending on a
slow and sustained suppression of the renin–
angiotensin–aldosterone axis.219 In addition,
0.9% saline produces a hyperchloraemic acido-
sis, which along with renal oedema, can lead
to a reduction in renal blood flow and renal
cortical perfusion, even in healthy human vol-
unteers.232
There are two relatively small randomized
clinical trials in humans comparing 0.9% saline
with Ringer’s lactate in the perioperative period,
showing that 0.9% saline caused more side
effects.235,236 One of these studies, involving
patients undergoing renal transplantation, had
to be stopped prematurely because, compared
with none in those receiving Ringer’s lactate,
19% of patients in the saline group had to be
treated for hyperkalaemia and 31% for meta-
bolic acidosis.235 In the other study, involving
patients undergoing abdominal aortic aneurysm
repair, those receiving saline needed more blood
products and bicarbonate therapy.236 Three
recent large observational studies200–202 have
suggested that 0.9% saline, because of the high
chloride content, may cause harm, especially to
the kidney. In a study using a validated and
quality assured database, evaluation of out-
comes in 2,788 adults undergoing major open
abdominal surgery who received only 0.9% sal-
ine and 926 who received only a balanced crys-
talloid on the day of surgery and showed that
unadjusted in-hospital mortality (5.6% vs.
2.9%) and the percentage of patients developing
complications (33.7% vs. 23%) were signifi-
cantly greater in the 0.9% saline group than in
the balanced crystalloid group.202 Patients
receiving 0.9% saline had significantly greater
blood transfusion requirements and more
infectious complications, and were 4.8 times
more likely to require dialysis than those receiv-
ing balanced crystalloids. Another recent study
provides support for chloride-restrictive fluid
strategies in critically ill patients.201 In an open-
label prospective sequential manner, 760
patients consecutively admitted to intensive care
(30% of whom were admitted after elective sur-
gery) received either traditional chloride-rich
solutions (0.9% sodium chloride, 4% succiny-
lated gelatin solution or 4% albumin solution)
or chloride-restricted (Hartmann’s solution,
Plasma-Lyte 148 or chloride-poor 20% albu-
min). After adjusting for confounding variables,
the chloride-restricted group had decreased inci-
dence of acute kidney injury [odds ratio 0.52
(95% CI 0.37–0.75), P < 0.001] and the use of
renal replacement therapy [odds ratio 0.52 (95%
CI 0.33–0.81), P = 0.004]. However, there were
no differences in hospital mortality, hospital or
ICU length of stay.201 A third study on 22,851
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surgical patients with normal preoperative
serum chloride concentration and renal function
showed that the incidence of acute postoperative
hyperchloraemia (serum chloride > 110 mmol/l)
was 22%.200 Patients with hyperchloraemia
were at increased risk of 30-day postoperative
mortality (3.0% vs. 1.9%; odds ratio 1.58 (95%
CI 1.25–1.98) and had a longer median hospital
stay [7.0 days (IQR 4.1–12.3) vs. 6.3 days (IQR
4.0–11.3)] than patients with normal postopera-
tive serum chloride concentrations.200 Patients
with postoperative hyperchloraemia were also
more likely to have postoperative renal dysfunc-
tion.
There is a strong signal suggesting that 0.9%
saline is harmful, particularly in the periopera-
tive period when compared with balanced solu-
tions199. However, there are currently no large-
scale randomized controlled trails that confirm
this finding. Nevertheless, it may be preferable
to use balanced crystalloids in the perioperative
period and restrict the use of saline to patients
who have alkalosis or have a hyperchloraemia
secondary to conditions such as vomiting or
high nasogastric tube aspirates, and in neuro-
surgical patients because of the relative hypo-
osmolarity of some of the balanced crystalloids.
Summary and Recommendations: 0.9% saline
should be avoided and balanced crystalloids
used in the preoperative period. The use of
0.9% saline should be restricted in hypochlo-
raemic and acidotic patients.
Recommendation: strong
Pain management
Multimodal, evidence-based and procedure-spe-
cific analgesic regimens should be standard of
care, with the aim to achieve optimal analgesia
with minimal side effects and to facilitate the
achievement of important ERAS milestones such
as early mobilization and oral feeding
(Table 2).237,238
Thoracic epidural analgesia (TEA)
TEA (T6-T11) remains the gold standard for post-
operative pain control in patients undergoing
open abdominal surgery.239 It still remains
unclear if epidural analgesia improves postopera-
tive outcomes. Although the results of a large
multicentre RCT failed to show a significant ben-
efit of using epidural analgesia in association
with general anaesthesia in reducing 30-day mor-
tality and postoperative morbidity in high-risk
patients240 a recent meta-analysis of 9044
patients undergoing surgery with general anaes-
thesia and receiving epidural analgesia (4525
patients) found that epidural analgesia is associ-
ated with a 40% reduction of mortality.241 Initia-
tion of neuroaxial blockade before surgery and
its maintenance throughout surgery decreases the
need for anaesthetic agents, opioids and muscle
relaxants.242 Compared with parenteral opioids,
epidural blockade has shown to provide better
postoperative static and dynamic analgesia for
the first 72 h,10, to accelerate the recovery of gas-
trointestinal function,243–245 to reduce insulin
resistance246 and impact positively on cardiovas-
cular and respiratory complications.241,247. How-
ever, hypotension, urinary retention pruritus and
motor blockade are common side effects.248
Although detrusor function can be impaired in
patients receiving TEA, a recent RCT has shown
that early removal of a urinary catheter (on post-
operative day 1) does not increase the risk blad-
der recatheterization and urinary infection.249.
Also TEA does not influence the duration of hos-
pital stay.250
The same benefits have not been observed
after laparoscopic procedures,59 especially in a
context of an ERAS programme.251–253 However,
TEA might still be valuable in patients at risk
of respiratory complications, in those with high
probability of conversion to laparotomy, or
requiring transverse or Pfannenstiel-like inci-
sions.254 Furthermore, TEA may be useful to
facilitate the recovery of bowel function even
after laparoscopic colorectal surgery.243
Clinical management
Epidural blockade should be tested before sur-
gery or in the immediate postoperative period
(post-anaesthesia care unit) to avoid non-func-
tioning epidurals and unnecessary opioid
administration.255 The addition of opioids to
local anaesthetic has shown to improve postop-
erative analgesia.248,256 Although a paucity of
studies have compared the analgesic efficacy of
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epidural solutions combining local anaesthetic
with lipophilic opioids vs. those containing
local anaesthetic combined with hydrophilic
opioids, epidural solution containing morphine
increase the risk of urinary retention.257,258
However, the use of low dose of local anaesthet-
ics (bupivacaine 0.1 mg/ml) and lipophilic opi-
oids (e.g. fentanyl 3 lg/ml) seem to provide
optimal analgesia with minimal side effects257.
Epidural morphine (0.02 mg/ml) in adjunct to
local anaesthetic can be preferred to lipophilic
opioids to increase segmental analgesia spread
and could be recommended for long midline
incisions.259 Epidural infusions can be contin-
ued for 48-72, gradually reducing infusion rates
and until the recovery of gastrointestinal func-
tion. Adding adrenaline (1.5–2.0 lg/ml) to
epidural mixture of local anaesthetic and fen-
tanyl improves postoperative analgesia, espe-
cially during mobilization and coughing, and
reduces pruritus and nausea.248,256,260–262 Evi-
dence on the analgesic efficacy of epidural cloni-
Table 2 Non-analgesic outcomes and current issues reported after abdominal surgery with different analgesic techniques.
Analgesia technique Outcomes ERAS Control group Complications/issues
Laparotomy TEA (low dose of LA
and opioids)
; PONV250 – SO Hypotension, pruritus,
bladder dysfunction248,249↑Recovery of bowel function244 – SO
;Insulin resistance246 – SO
;Respiratory complications247 – SO
↑Health-related quality of life353 – SO
= LOSH250 – SO
IT morphine Health-related quality of life354 ✓ SO Respiratory depression,
pruritus, bladder dysfunction265
IVLI Anti-inflammatory269 – SO LA toxicity270
↑Recovery of bowel function269 – SO
;LOSH269 – SO
= LOSH254 ✓ TEA
CWI LA ;/↑/= Recovery of bowel
function275–277,355
✓/– SO;TEA Ideal anatomic location not
determined274
;/↑/= LOSH273,275,276 – SO;TEA
Abdominal trunks
blocks
;Postoperative sedation284,289 – SO Timing, dose, volume of LA,
technique297;PONV283 – SO
Laparoscopy TEA ↑/=/; Recovery of bowel
function243,253,254
✓/– SO;IVLI;IT/TAP Hypotension, pruritus, bladder
dysfunction248,249
↑/= LOSH253,254 ✓ SO;IT;TAP
IT morphine = Recovery of bowel
function253,268,356
✓ SO;TEA Respiratory depression, pruritus,
bladder dysfunction265
Facilitate mobilization356 ✓ TEA
;/= LOSH253,268 ✓ SO;TEA
23-h LOSH after laparoscopic
colectomy357
✓ –
IVLI Anti-inflammatory269(; IL-6, IL1-R) – SO LA toxicity270
↑/= Recovery of bowel
function254,272
✓ SO;TEA
= LOSH254 ✓ TEA
Abdominal
trunksblocks
23-h LOSH after laparoscopic
colectomy286
✓ SO Timing, dose and volume of LA,
technique297
= LOSH295 ✓ SO
= LOSH, earlier urinary catheter
removal296
✓ TEA
;, decreasing; ↑, accelerating; =, no effect. SO, systemic opioids; TEA, thoracic epidural analgesia; IVLI, intravenous lidocaine infusion; CWI,
continuous wound infusion; LA, local anaesthetic; LOSH, length of hospital stay in hospital; (ERAS), study within an ERAS programme.
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dine is inconclusive and the risk of hypotension
and sedation is increased.263 Hypotension
induced by epidural blockade should be treated
with vasopressors as first choice provided the
patient is not hypovolaemic. Orthostatic
hypotension associated with postoperative
epidural analgesia does not impair the ability to
ambulate.264 Institutional policies on how to
manage epidural side effects, terminate epidural
infusions, and how transition to oral multi-
modal analgesia are recommended.
Intrathecal (IT) analgesia. IT morphine is a valu-
able analgesic technique to improve early post-
operative analgesia265 and facilitates surgical
recovery.266 However, compared with systemic
opioids, the incidence of pruritus (OR 3.85,
95% CI 2.40–6.15) and respiratory depression
(although rare) is increased (OR 7.86, 95% CI
1.54–40.3). Postoperative urinary retention is
also slightly more frequent (OR 2.35, 95% CI
1.00–5.51).265 Hypotension in the first 12 h,
especially in a context of an enhanced recovery
pathway and a restrictive fluid management, has
been also associated with the use of intrathecal
hydromorphone (with bupivacaine or cloni-
dine).267
In the light of these side effects, in the con-
text of an multimodal analgesic regimen other
regional anaesthesia technique could be
favoured especially in elderly patients. Behind
providing excellent analgesia,268 IT morphine
seems an appealing technique to shorten hospi-
tal stay in low-risk patients undergoing laparo-
scopic colorectal surgery with an ERAS
protocol.253
Clinical management
Reported IT morphine dosage range between
200 and 250 lg in patients aged ≤ 75 years to lg
150 in patients > 75 years of age. Isobaric or
hyperbaric bupivacaine (10–12.5 mg) have been
used in conjunction with IT morphine.253,268
Intravenous lidocaine (IVL) infusion
In view of its antinociceptive and anti-inflam-
matory properties, systemic administration of
IVL as adjuvant to systemic opioids has been
shown to improve postoperative analgesia,
reduce opioid consumption and speed surgical
recovery.269,270 Similar benefits have been
observed after laparoscopic abdominal surgeries
when compared with systemic opioids,271 but
not when compared with TEA254, and especially
in the absence of an ERAS programme.254,272
Clinical management
A loading dose of 1.5 mg/kg (IBW) should be
initiated 30 min before or at the induction of
anaesthesia and continued until the end of
surgery or in the recovery room (2 mg/kg/h
IBW). The exact duration of the infusion provid-
ing optimal analgesia and facilitating also recov-
ery remains unknown. Systemic toxicity is rare,
but continuous cardiovascular monitoring is
required.270
Continuous wound infusion (CWI) of local
anaesthetic. CWI of local anaesthetic after open
abdominal surgery has been shown to improve
postoperative analgesia and reduce opioid con-
sumption,273,274 however the effect on the
recovery of bowel function is unclear.273,275
Two recent RCTs have compared the analgesic
efficacy of CWI of local anaesthetic with TEA
but the results are contrasting.276,277 A recent
feasibility study has compared the analgesic
efficacy of CWI of local anaesthetic with epidu-
ral analgesia after laparoscopic abdominal sur-
gery. Pain intensity was similar among patients
receiving epidural and CWI of local anaes-
thetic.278
Despite promising results the analgesic effi-
cacy of CWI of local anaesthetic remains incon-
clusive and several aspects related to this
techniques need to be clarified. For example,
although preperitoneal multihole catheters have
consistently provided satisfactory analgesia, and
subfascial catheters have provided better results
than suprafascial catheters,279 the anatomical
location associated with optimal recovery
remains undetermined.274,279 Furthermore, it
remains to be established if the analgesic effect
observed in different trials is mainly driven by
the bolus of local anaesthetic commonly given
at the end of surgery or by the infusion of local
anaesthetic during the postoperative period.280
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Clinical management
Preperitoneal continuous infusion of ropiva-
caine 0.2% (10 ml/h) for 48–72 h has been
used in the majority of the studies. Other
amide-local anaesthetics have also been used.
Systemic opioids are still required to control
visceral pain.
Abdominal trunk blocks: transversus abdominis plane
(TAP) block and rectus sheath block. Significant
reduction of pain intensity and opioid consump-
tion after ultrasound-guided single-shot TAP
blocks has been observed but it is limited to the
first 24 h after surgery.281–283 TAP blocks can
also be performed by surgeons from the peri-
toneal cavity before closing the abdominal
wall,284,285 or laparoscopic guided.286–288 Few
studies have reported a reduction of some of the
opioids side effects such as nausea and vomit-
ing283 or sedation,284,289 but these results have
not been reproduced consistently.281 Continuous
infusion or intermittent administration of local
anaesthetics through multihole catheters placed
in the transversus abdominis plane have been
used to improve and prolong opioid-based post-
operative analgesia up to 48–72 h after abdomi-
nal surgery, but the evidence supporting the
analgesic efficacy of TAP-infusion of local anaes-
thetic remains scarce and inconclusive.290–292
Niraj et al. found that epidural analgesia did
not provide better visual analogue scores dur-
ing coughing than intermittent local anaesthetic
boluses through bilateral subcostal TAP cathe-
ters in the first 72 h after upper abdominal
surgery.293 However, epidural failure rate
were high (22%) and almost half of the TAP
catheters had to be replaced in the postoperative
period.
Similar benefits have been reported in abdom-
inal laparoscopic procedures282,294 and in a con-
text of an ERAS programme.286,295 Despite
facilitating hospital discharge,286 bilateral sin-
gle-shot TAP blocks seem to do not reduce hos-
pital stay after laparoscopic colorectal
surgery.295 A recent RCT has shown that the
analgesic efficacy of four-quadrant TAP blocks
in adjunct to bilateral posterior continuous TAP
blocks, was not inferior to TEA after laparo-
scopic colorectal surgery.296
Clinical management
Optimal timing, choice of local anaesthetic, dos-
ing and volumes remain unknown.297 However,
it seems that a minimal volume of 15 ml is
required to achieve satisfactory analgesia with
single-shot TAP block.297 Ropivacaine 0.2% (8–
10 ml/h) can be infused for 48–72 h trough a
multihole catheter. A bilateral infusion (8–
10 ml/h each side) is required with a midline
incision. Systemic opioids are needed to control
visceral pain.
More studies that further validate the anal-
gesic efficacy of TAP blocks are warranted.
Intraperitoneal local anaesthetic (IPLA) . The results
of a meta-analysis including eight RCTs have
shown that IPLA after open abdominal surgery
reduce postoperative pain scores but not opioid
consumption. However, in the latest randomized
control trial conducted in a context of an
enhanced recovery programme, IPLA improved
surgical recovery, reduced postoperative pain
and opioid consumption in patients undergoing
open colectomy and receiving thoracic epidural
analgesia.298
IPLA has been shown to improve postopera-
tive analgesia, reduce shoulder pain and opioid
consumption after laparoscopic gastric sur-
gery299.
Multimodal analgesia (MMA). A MMA regimen
based on routine use of NSAIDs, COX-2 and
acetaminophen (paracetamol) (PO or intra-
venously when available) should adopted if not
contraindicated in patients undergoing open
and laparoscopic abdominal procedures with
the aim to reduce opioid consumption and their
dose-dependent side effects that impair recov-
ery.300 NSAIDs and COX-2 inhibitors have been
shown to improve postoperative analgesia,
reduce opioid consumption and some of their
side effects by 30%.301 There have been recent
concerns about the risk of anastomotic leakage
and the use of NSAIDs or COX-2 inhibitors
after colorectal surgeries based on experimental,
retrospective and case-series studies.302. Large
RCTs are needed to confirm these results. The
risk of anastomotic leakage after bowel surgery
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was not significantly increased in a recent meta-
analysis of six RCTs (480 patients) of patients
receiving at least one dose of NSAIDs or COX-2
inhibitors within 48 h of surgery (Peto OR 2.16
[95% CI 0.85–5.53, P = 0.11])303. This effect
seems to be molecule-specific (diclofenac is
associated with the highest risk)302 and class-
specific (risk of anastomotic leakage with
NSAIDs, OR 2.13 [95% CI 1.24–3.65],
P = 0.006, risk of anastomotic leakage with
selective COX-2 inhibitors OR 1.16 [95% CI
0.49–2.75] P = 0.741)304. Furthermore, the risk
varies with duration of the treatment, and it is
higher after 3 days or more of NSAIDs than after
1 or 2 days only304. Acetaminophen (paraceta-
mol) has shown to improve postoperative anal-
gesia, have an opioid-sparing effect, but not
reduce opioids side effects.305 However, a recent
meta-analysis has demonstrated that intravenous
paracetamol reduces the risk of postoperative
nausea and vomiting, but this effect seems more
related to an improvement in postoperative pain
rather than to a reduction in opioid consump-
tion.306 Concerns have been raised about the
cardiovascular risk and delayed bone healing
associated with the use of NSAIDs and COX-2
inhibitors307. Overall, the evidence is inconclu-
sive307 and does not support the avoidance of
short perioperative NSAIDs and COX-2 inhibi-
tors treatment in patients with low cardiovascu-
lar risk.307,308 High-dose of systemic steroids
have also shown promising results309,310, also in
patients not undergoing gastrointestinal sur-
gery.311,312 Perioperative intravenous ketamine
and gabapentinoids have also shown opioid-
sparing properties.313,314 However, the risk of
side effects such as dizziness and sedation
should be considered. An opioid-free ultimodal
analgesic strategy based mainly on analgesic
adjuvants would be appealing but more studies
are warranted to establish the feasibility, effi-
cacy and safety of such analgesic approaches.315
Wound infiltration with long-acting multivesic-
ular liposome formulation of bupivacaine as part
of multimodal analgesic regimens has also
shown promising results.316,317 It must be
acknowledged that most of the following recom-
mendations come from studies not using
enhanced recovery after surgery (ERAS)
programmes. It might be possible that the
well-proven benefits of ERAS programmes
might offset the reported advantages of different
analgesic techniques.242 The synergistic effect of
combining different analgesic medications
remains unknown and the impact of MMA
on long- term outcomes still remains to be
determined318.
Summary and Recommendation: Analgesic tech-
niques should aim to not only provide optimal
pain control but also to facilitate the achieve-
ment of important milestones such as tolerance
of oral intake, and early mobilization. Opioid
side effects are dose-dependent and delay recov-
ery. Opioid-sparing analgesic strategies, includ-
ing regional analgesia techniques, should be
implemented in a context of a multimodal anal-
gesic regimen. Postoperative pain management
should be procedure-specific.
Recommendation grade: MMA: strong
Open abdominal surgery. TEA: strong for using
it
IVLI: moderate for using it
CWI: weak for using it
TAP blocks: moderate for using it
Laparoscopic abdominal surgery. TEA: weak for
using it
IVLI: moderate for using it
Intrathecal morphine: moderate for using it
TAP blocks: moderate for using it
Postoperative delirium
Postoperative delirium is increasingly recognized
in surgical practice, particularly in the elderly
population who have pre-existing cognitive dys-
function. While delirium can be a symptom of a
surgical or medical complication it is important
to be recognized instantly.
The prevalence is underestimated and under-
diagnosed if no systematic monitoring is
applied.319 It is defined as a condition of
altered consciousness, orientation, memory,
thought, perception, behaviour and possibly
sleep pattern which develops acutely and
shows a fluctuating clinical course.320 Delirium
can be classified into three subtypes: the hyper-
active delirium, the hypoactive delirium and a
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mixed form.321 Delirium as a symptom of acute
cerebral dysfunction should not solely be per-
ceived as a strictly binary phenomenon which
is either present or absent. Detection of delir-
ium also at pre-delirium or sub-syndromal
levels could prevent further deterioration of
cerebral function.
Undetected and untreated or delayed treat-
ment of delirium does increase the rate of com-
plications, the length of hospital stay as well as
mortality322,323 and is associated with long-term
cognitive dysfunction.324
Early detection in the postoperative setting is
a prerequisite for finding and treating the
underlying causes. Numerous validated Delir-
ium Instruments have been validated for clinical
use.325,326
Delirium promoting factors such as pro-
longed preoperative fluid fasting times, deep
anaesthesia time as well as disturbing the
sleep–wake cycle and the use of sedatives and
other delirogenic medications should be
avoided.117,327
If postoperative delirium is detected, the early
symptomatic therapy based on pharmacological
and non-pharmacological measures, is associ-
ated with a decreased mortality323. Psychotic
symptoms should be treated with neuroleptics.
A systematic review that a low-dose haloperidol
therapy compared with a therapy with atypical
neuroleptics has a similar effectiveness and side
effect rate.328
If there is the necessity to apply substances
with sedative properties, non-benzodiazepines
should be preferred (e.g. alpha-2-agonists) due
to international guidelines for sedation. Benzo-
diazepines are known to be an independent risk
factor for delirium and should therefore be
avoided if possible.329
Summary and recommendation: Preventive
measure as avoidance of prolonged fasting,
deep anaesthesia, disturbance of sleep–wake
cycle or delirogenic medications like benzodi-
azepines, atropine should be implemented. Sys-
tematic delirium screening and symptom-
oriented treatment should be performed and
potential underlying medical causes should be
ruled out.
Recommendation grade: strong.
Attenuation and treatment of postoperative
ileus
Postoperative ileus (POI) is defined as a tran-
sient reduction of bowel motility that prevents
effective transit of bowel content and tolerance
of oral intake following surgical interven-
tions.330 POI has been associated with pro-
longed hospital stay and higher risk of
complications. POI can be classified in primary
POI that occurs in the absence of surgical com-
plications, and in secondary POI in the presence
of surgical complications such as anastomotic
leakage, abscess, peritonitis, etc.330 Primary POI
is considered an inevitable consequence after
abdominal surgery. However, its clinical presen-
tation and duration can significantly vary among
patients depending on the severity of the gas-
trointestinal dysfunction. Some patients can be
totally asymptomatic and tolerate oral intake in
the immediate postoperative period, while
others experience gastrointestinal symptoms,
cannot tolerate any oral intake for several days
and might require insertion of a nasogastric tube
(NGT).330 The definitions of primary POI
remains elusive and many clinical trials still uti-
lize personal definitions in view of the difficulty
on how to clinically identify patients with a
clinically relevant impairment of gastrointestinal
dysfunction. In a recent study measuring the
gastrointestinal transit after colorectal surgery,
Van Bree et al. showed that the combination of
tolerance of solid food and passage of stool best
correlates with the recovery of gastrointestinal
function (area under the curve 0.9, SE 0.04,
95% CI 0.79–0.95, P < 0.001), with a positive
predictive value of 93% (95% CI 78–99).331 It
also best predicts hospital stay.331 Others clini-
cal indicators commonly used to assess POI,
such as the time to first flatus, poorly correlate
with the recovery of the gastrointestinal func-
tion.331 A list of clinical indicators commonly
used in clinical practice to evaluate the recovery
of the gastrointestinal function is reported in
Fig. 1. Non-ileus-related nausea and intra-
abdominal surgical complications leading to sec-
ondary POI should be excluded.
Due to its multifactorial pathogenesis several
perioperative preventive strategies can be imple-
mented to reduce the severity and duration of
primary POI.332 Based on the results of a large
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retrospective study, it should be also considered
that some patients might have a higher risk to
develop prolonged primary POI (Table 3). These
results need to be confirmed when adopting
multiple interventions to attenuate postoperative
gastrointestinal dysfunctions as in a context of
an ERAS programme.333 Nasogastric decompres-
sion should be considered to prevent complica-
tions such as pulmonary aspiration and
arrhythmias.164
Summary and recommendation: Primary POI is
an inevitable consequence after gastrointestinal
surgery and its pathogenesis is multifactorial.
Multimodal preventing strategies should be
adopted to facilitate the recovery of gastroin-
testinal function.
Recommendation grade: moderate
Early mobilization
Although the tradition of prolonged postopera-
tive bed rest was abandoned over 75 years
ago334 and the dangers of staying in bed
acknowledged,335 modern surgical patients actu-
ally spend very little time out of bed.336 Early
“enforced” or “structured” mobilization is a key
component of virtually all ERAS pro-
grammes.16,337 Patients cared for with the ERAS
paradigms mobilize more and achieve indepen-
dent mobilization earlier than those cared for
without ERAS.7 Mobilization helps preserve
Table 3 Risk factors, prevention and management of primary
POI.
Patients risk factors333
• Male
• Cerebrovascular diseases
• Respiratory diseases
• Peripheral vascular diseases
Intraoperative strategies to accelerate the recovery of
gastrointestinal function
• Laparoscopic surgery5
• Thoracic epidural analgesia241
• Opioid-sparing strategies332
o Intravenous Lidocaine
o NSAIDs/COX-2
o Ketamine
• Avoid fluid excess and splanchnic hypoperfusion332
Postoperative strategies to accelerate the recovery of
gastrointestinal function
• Thoracic epidural analgesia241
• Opioid-sparing strategies332
o NSAIDs/COX-2
• Opioid antagonists358
o Alvimopam
o Metiltrexone
• Mobilization332
• Laxative332
• Gum-chewing359
• Administer IV fluids only if clinical indicated (surgical losses,
inadequate hydration) (ref)
• Early feeding332
• Avoidance prophylactic and routine use of NGT
Treatment of primary POI
NGT insertion332
Fig. 1. Identification of patients with primary
or secondary postoperative Ileus (POI). SIRS,
systemic inflammmatory response; WBC,
white blood cell; Hb, hemoglobin; K+,
potassium; HPO4
2, phospate.
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muscle function and prevent complications
associated with bed rest, but also aligns with
the message of empowerment of patients to play
an active role in their own recovery after sur-
gery; this term is used instead of “convales-
cence”, which implies a passive process.
Protocols differ between pathways and there
is no standard definition of early mobilization
which may include exercising in bed, sitting out
of bed, standing, walking in the room, walking
in the hallway or exercising.338 Different
successful pathways set different mobilization
goals using different benchmarks such as time7
(hours out of bed, hours sitting or walking) or
distance (e.g. number of times to walk a hall-
way or ward).339 These begin early, on the day
of surgery, and increase each day to reach prede-
termined targets. There are no data to support
the use of one plan over another or suggestion
of a “dose–response” curve related to outcomes.
Unfortunately, there is little evidence avail-
able to guide how to best achieve early mobi-
lization and even within established ERAS
programmes adherence to mobilization targets
may be quite low, suggesting a need for specific
studies in this area.197 A review of the impact of
early mobilization for medical and surgical
patients found that the use of a more standard-
ized and structured approach beginning as early
as possible had the most favourable results.340
This begins in the preoperative setting with
clear and explicit instructions detailing daily
mobilization goals. These instructions are rein-
forced with written material which improves
recall341 and which is brought by the patient to
the hospital. Posters on the ward may help rein-
force daily goals.342 Patients who begin an exer-
cise programme in the preoperative period may
also be more likely to be physically active post-
operatively.343 Compliance may be improved by
the use of a patient diary344 or when a pedome-
ter is worn, which has been shown in other
contexts to be associated with increased physi-
cal activity.345 Creation of separate ERAS “reha-
bilitation” wards344 or having a separate ward
dining room may help337 but are not feasible in
all settings. The absence of an in-room enter-
tainment system may promote increased walk-
ing.346 Having an audit tool available recording
compliance with mobilization is important to
identify and address barriers.
Achieving early mobilization on the ward
requires integration between the patient and the
various health care providers working in a multi-
disciplinary fashion form the beginning. Pain and
drains inhibit ambulation.338 Ideally a dedicated
pain service is involved in the ERAS team to opti-
mize pain control and reduce side effects.337
Epidural analgesia provides excellent analgesia
after open abdominal or thoracic surgery but it is
associated with postoperative hypotension and
with lower limb weakness if the epidural block is
extended to the lumbar nerve roots.248 Epidural
systems that reduce interference with ambulation
should be used if possible. There is a tendency to
bed rest patients experiencing orthostatic intoler-
ance or hypotension, and to consider the epidural
responsible for this effect. However, in patients
with thoracic epidural analgesia hypotension is a
relatively common side effect on postoperative
day 1 but is often asymptomatic and does not pre-
dict the ability to walk.264 Furthermore, epidural
analgesia is not associated with higher risk of
orthostatic intolerance or hypotension than sys-
temic opioids.347 Orthostatic intolerance seems to
be more related to an impairment of the auto-
nomic system and to an alteration of the barore-
ceptor reflex348,349 rather than to other factors such
as hypovolaemia,350 anaemia and pain.349 The
underlying mechanisms are not yet fully
understood.
Most pathways rely on nurses to assist with
“enforcing” mobilization7 with physiotherapists
involved in some programmes, suggesting an
increased need for resources. Nurses should be
involved in the creation of the mobilization plan
from the beginning in order for the team to
understand potential barriers to ambulation.351
Although there may be concern from nurses that
ERAS will increase their daily workload related
to these physical tasks, this has not been shown
to be the case, perhaps because of increased
patient independence.352
Summary and recommendation: Achievement of
mobilization goals requires a multidisciplinary
approach. Patients should be given written
information setting daily targets for ambulation
in hospital. Patients should be encouraged to
increase their physical activity in the preopera-
tive period. Patients should use a diary or
pedometer to record their daily physical activity.
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Table 4 ERAS elements: summary and recommendations.
Perioperative element Summary and recommendation Recommendation grade
Risk assessment Preoperative scoring tools and functional capacity tests can be
used to identify patients at risk of complications and to stratify
perioperative risk.
POSSUM: strong
Lee Index: strong
Cardiovascular Risk Calculator: strong
Walk tests: strong
CPET: strong
General Surgery Acute Kidney Injury
Risk Index: strong
Preoperative
optimization
Cessation of smoking and alcohol intake at least 4 weeks before
surgery is recommended. Encouraging patients is not enough;
pharmacological support and individual counselling should be
offered to every patient who smokes and to alcohol abusers
undergoing elective surgery. Optimization of medical conditions,
such as cardiovascular diseases, anaemia, COPD, nutritional
status and diabetes should follow international
recommendations.
Smoking cessation: high
NRT and counselling: high
Alcohol cessation: low
Medical optimization: strong
Optimize preoperative anaemia
reduces morbidity and mortality:
moderate
Pre-anaesthetic
medication
Long-acting anxiolytic and opioids should be avoided as they may
delay discharge. Short-acting benzodiazepine should be avoided
in the elderly.
Strong.
Preoperative fasting
and carbohydrates
(CHOs) loading
Intake of clear fluids should be allowed until 2 h before induction
of anaesthesia. Solids should be allowed until 6 h. Preoperative
treatment with oral CHOs should be routinely administered
except in patients with documented delayed gastric emptying or
slow gastrointestinal motility and as well in patients undergoing
emergency surgery.
Adherence to fasting guidelines (avoid
overnight fasting): strong
Administration of preoperative CHOs:
strong
Administration of preoperative CHOs
in diabetic and obese patients: weak
Preventing and
treating
postoperative
nausea and
vomiting (PONV)
Aggressive PONV prevention strategy should be included in an
ERAS protocol102. All patients with 1–2 risk factors should
receive a combination of two antiemetics. Patients with 3–4 risk
factors should receive 2–3 antiemetics. Total intravenous
anaesthesia (TIVA) with propofol and opioid-sparing strategies
should be encouraged.
Strong
Standard anaesthetic
protocol
Anaesthetic depth should be guided either maintaining an end
tidal concentration of 0.7–1.3 MAC or BIS index between 40 and
60 with the aim not only to prevent awareness but also to
minimize anaesthetic side effects and facilitate rapid awakening
and recovery. Avoid too deep anaesthesia (BIS < 45), especially
in elderly patients
Strong
Neuromuscular
blockade (NMB) and
neuromuscular
monitoring
It remains controversial if deep neuromuscular blockade during
laparoscopic surgery improves operating conditions.
Neuromuscular function should be always monitored when
using NMBA to avoid residual paralysis. Long-acting NMBA
should be avoided. When NMBA are administered
neuromuscular function should be monitored by using a
peripheral nerve stimulator to ensure adequate muscle
relaxation during surgery and optimal restoration of
neuromuscular function at the end of surgery. A TOF ratio of
0.9 must be achieved to ensure adequate return of muscle
function and thus preventing complications.
Monitoring neuromuscular function:
strong
Reversing neuromuscular blockade:
strong
Inspired Oxygen
Concentration
1) The inspired fractional concentration of oxygen should be
titrated to produce normal arterial oxygen levels and
saturations. Prolonged periods of high inspired oxygen
concentrations which result in hyperoxia should be avoided.
1) Strong
2) Strong
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Table 4 (Continued)
Perioperative element Summary and recommendation Recommendation grade
2) 100% inspired oxygen concentrations can be used for pre-
oxygenation prior to anaesthesia or for short periods to
overcome hypoxia.
Preventing
intraoperative
hypothermia
Intraoperative hypothermia should be avoided by using active
warming devices.
Strong.
Surgical techniques Laparoscopic surgery for gastrointestinal surgery is recommended
when the expertise is available. Transverse incisions for colonic
resections can be preferred.
Laparoscopic approach: strong
Transverse incisions for colonic
surgery: low
Nasogastric intubation Prophylactic use of NGTs is not recommended for patients
undergoing elective colorectal surgery, while its use in patients
undergoing gastrectomy and oesophagectomy is still debatable.
Patients with delayed gastric emptying after surgery should be
treated by inserting a NGT.
Strong.
Intraoperative
glycaemic control
Glucose levels should be kept as close to normal as possible
without compromising safety. Employing perioperative
treatments that reduce insulin resistance without causing
hypoglycaemia is recommended.
Strong.
Perioperative
haemodynamic
management
The goal of perioperative fluid therapy is to maintain fluid
homeostasis avoiding fluid excess and organ hypoperfusion.
Fluid excess leading to perioperative weight gain more than
2.5 kg should be avoided, and a perioperative near-zero fluid
balance approach should be preferred. GDFT should be adopted
especially in moderate–high-risk patients. Inotropes should be
considered in patients with poor contractility CI < 2.5 l/min).
Colloids should not be used in septic patients and in patients
with reduced renal function. Large amount of colloids can
impair haemostasis. In patients receiving epidural analgesia
arterial hypotension should be treated with vasopressors,
ensuring the patient is normovolaemic. In the absence of
surgical losses postoperative intravenous fluid should be
discontinued and oral intake (1.5 l/day) encouraged.
GDFT: Strong in high-risk patients and
for patients undergoing surgery with
large intravascular fluid loss (blood
loss and protein/fluid shift)
GDFT: low in low-risk patients and in
patients undergoing low-risk surgery
Perioperative near-zero fluid balance:
moderate
Use of advanced hemodynamic
monitoring: strong in high-risk patients
and for patients undergoing surgery
with large intravascular fluid loss
(blood loss and protein/fluid shift)
Balanced crystalloids
vs. 0.9% saline
0.9% saline should be avoided and balanced crystalloid solution
used in the preoperative period. The use of 0.9% saline should
be restricted in hypochloraemic and acidotic patients.
Strong
Pain management Analgesic techniques should aim to not only provide optimal pain
control, but also to facilitate the achievement of important
milestones such as tolerance of oral intake, and early
mobilization. Opioids side effects are dose-dependent and delay
recovery. Opioid-sparing analgesic strategies, including regional
analgesia techniques, should be implemented in a context of a
multimodal analgesic regimen. Postoperative pain management
should be procedure-specific
MMA: strong
Open abdominal surgery
TEA: strong for using it
IVLI: moderate for using it
CWI: weak for using it
TAP blocks: moderate for using it
Laparoscopic abdominal surgery
TEA: weak for using it
IVLI: moderate for using it
Intrathecal morphine: moderate for
using it
TAP blocks: moderate for using it
Postoperative
Delirium
Preventive measure as avoidance of prolonged fasting, deep
anaesthesia, disturbance of sleep-wake cycle or delirogenic
medications like benzodiazepines, atropine should be
implemented. Systematic delirium screening and symptom-
Strong
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Recommendation grade: weak.
Comment
The practice of surgery and anaesthesia is con-
tinuously evolving and there is a need to offer
the knowledge base for continuous training of
those involved in the treatment of surgical
patients. The ERAS Society (www.erassoci-
ety.org) was initiated by the former ERAS Study
Group and was formed in 2010 to support these
processes. The multidisciplinary Society partici-
pates in the improvement of perioperative care
by developing new knowledge through
research, education and also by being involved
in the implementation of best practice.
The current manuscript presents a consensus
review from the ERAS Society, discuss clinical
considerations, and provide recommendations,
for optimal anaesthesia care within the ERAS
programme for patients undergoing gastroin-
testinal surgery. The quality of evidence sup-
porting each ERAS element has been already
evaluated according to the GRADE system and
previously published15–19. The evidence-based
recommendations present the ERAS protocol
interventions separately and overall, and are
intended to be used by units undertaking to
implement and upgrade to what the current lit-
erature shows to be best practice: the ERAS pro-
tocol. It must be acknowledged that, not being a
systematic review, all articles quoted in the
manuscript have been selected by the expert in
each area, resulting in potential bias. Clinical
considerations and recommendations for each of
the ERAS elements are listed in Table 4.
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